The Mini-Fellowship › The mentorship year

Twelve months of mentorship, after the four days

The course ends at two o’clock on Sunday. The harder questions arrive in the weeks after it, when the first patients are booked and the protocols meet a real practice. That year is part of the program, not an add-on to it.

The course director reviewing a case with a graduate
LengthTwelve months from the course
AccessDirect to the clinical team
StructureQuarterly milestones
ClosingCompetency re-assessment at 12 months
NetworkGraduate board and regulatory updates
CostIncluded in tuition

Why the year exists

Competence is demonstrated in four days. Confidence takes longer.

By Sunday afternoon a participant has run complete infusions under observation and passed the assessment. What has not happened yet is the first patient of their own, in their own room, with their own staff, on a Tuesday, when something does not go to plan.

That is what the mentorship year is for. For twelve months, graduates can bring any of it back: a patient who is not responding, a reaction that was not expected, a genetic result that is hard to read, a state rule that is not clear, a piece of equipment that turns out to be wrong for the room.

The point is not reassurance. It is that decisions made in the first year set how a practice runs for years afterward, and they are better made with someone who has made them before.

How it works

Call 800-850-6979 or email training@ketamineinstitute.com and we arrange a time to talk the case through.Bring the record, the medication list and what you have already tried.

Who you speak to

The clinical team, and Dr. Grass for the cases that need him.

Milestones

Four checkpoints across the year, so the mentorship follows the practice rather than waiting for a crisis.

Records

What is discussed and decided can be recorded in your own notes; the competency portfolio from the course is yours to build on.

Privacy

Case discussions are clinician to clinician. Bring only what the question needs.

The year, quarter by quarter

What usually comes up, and when.

Every practice is different, and the year follows yours. These are the questions that arrive most often, in the order they tend to arrive.

Months 1–3

Opening, or reopening

Protocols and standard operating procedures adapted to your site, equipment and vendor decisions, controlled-substance setup, and the first patients booked. Early cases are reviewed as they happen.

Months 4–6

Harder cases

Complex medication lists, comorbidity, patients who do not respond as expected, and the first decisions about changing a target or a series. Documentation reviewed against what a board or carrier would look for.

Months 7–9

Running a service

Series management across a caseload, measurement kept consistent, referral relationships, and the operational questions that surface once volume grows.

Months 10–12

Review and re-assessment

A competency re-assessment, a review of outcomes and complications from the year, and what to change for the year ahead.

What graduates bring

Eight kinds of question, all of them welcome.

A dosing question

A patient whose response does not match the plan, and what to change before the next infusion.

An unexpected reaction

What happened, what was done, and how to prepare for it next time.

A genetic or laboratory result

Pharmacogenomic reports, thyroid, testosterone, magnesium and carnitine findings, and whether they should change anything.

A complex medication list

Interactions that blunt or amplify the response, and how to sequence changes with the prescribing clinician.

A patient who is not responding

Working through selection, optimization, target and technique before concluding that ketamine is not for them.

An equipment or vendor decision

Pumps, monitors, ketamine supply and the practical trade-offs.

A documentation or regulatory question

What your state expects, what to record, and how to keep the controlled-substance program inspection-ready.

Language for patients and referrers

How to describe your training and methods accurately, without overstating what the treatment does.

Beyond the one-to-one

The graduate network.

The graduate discussion board

Cases, questions and developments in the field, among clinicians trained in the same method.

Regulatory updates

Notice when a state or federal development affects office-based ketamine practice. The public version is kept on the regulatory landscape page.

The directory

Graduates who complete the assessment can be listed in KRI’s directory of trained clinicians, which patients and referring clinicians use to find someone near them.

Continuing contact

The Institute stays in touch after the first year; graduates are welcome to keep bringing cases.

Find a KRI-trained clinician →   What graduates say →

At twelve months

The re-assessment that closes the year.

The year ends the way the course did, with a structured look at what a graduate is actually doing in practice.

Clinical reasoning

A structured review of cases from the year: selection, targets, adjustments and stopping decisions.

Documentation

A sample of records reviewed against anesthesia-standard documentation and your state’s requirements.

Outcomes

What your own measurement shows across the year, and what it suggests about technique.

What comes next

Where to take the practice, and what further training, if any, would serve it.

The assessment and the credential →

Private mentorship

A smaller number of clinicians work one to one with Dr. Grass.

Separately from the Mini-Fellowship, a limited number of clinicians arrange private mentorship built entirely around their own practice, patients and pace. Practice-readiness sessions for a clinician and their staff can be arranged the same way.

To discuss either, call 800-850-6979 or email training@ketamineinstitute.com.

The course director in the infusion center

Four places in each session

Four clinicians at a time, in Sarasota. We set the dates with each cohort rather than publishing a calendar. For current availability, call 800-850-6979 or email training@ketamineinstitute.com.